Commercialization Progress (Stereax)Qualified production at Cirtec and initial M300 customer deliveries with a first cathode purchase order materially de-risks early commercial execution. A contracted manufacturing partner and real customer orders create a tangible pathway to recurring revenue and scale, supporting durable commercialization prospects over the next 2–6 months and beyond.
IP-backed, Asset-light Licensing ModelA 78‑patent portfolio combined with an asset-light licensing approach diversifies future revenue channels (NRE, cathode work, royalties). This structural model reduces capital intensity versus captive manufacturing, creates scalable margin potential as partners adopt technology, and raises barriers to entry over the medium term.
Scale-up Validated On Gigafactory EquipmentDemonstrated compatibility with UKBIC gigafactory equipment, with improved yields and capacity, lowers industrialization risk. Proven performance on standardized manufacturing lines supports predictable margin expansion and faster customer adoption, making commercial scale-up and OEM integration more feasible over a multi-quarter horizon.